Concepedia

Finn D. Wolfreys

FD

5

Publications

255

Citations

5

H-Index

2016

Active since

Affiliations

Howard Hughes Medical Institute(Current)

University of California, San Francisco

Goethe University Frankfurt

University of Oxford

Genomics (United Kingdom)

Finn D. Wolfreys is an author at Howard Hughes Medical Institute specializing in drug discovery, medicine, and pharmacology.

Top concepts

MedicineBiochemistryPharmacologyDrug DiscoveryNatural SciencesMedicinal ChemistryMolecular PharmacologyCell BiologyCell SignalingCancer Research

Publications per year

2016–2021

5

Publications

5

S-Geranylgeranyl-l-glutathione is a ligand for human B cell-confinement receptor P2RY8

Erick Lu, Finn D. Wolfreys, Jagan Muppidi et al. · Nature · 2019 · 87 citations · Full text

Molecular Pharmacology, Biochemistry, G Protein-coupled Receptor +6

Halogen–Aromatic π Interactions Modulate Inhibitor Residence Times

Christina Heroven, Victoria Georgi, Gaurav K. Ganotra et al. · Angewandte Chemie International Edition · 2018 · 68 citations · Full text

Molecular Docking, Molecular Pharmacology, Medicinal Chemistry +14

P2RY8 variants in lupus patients uncover a role for the receptor in immunological tolerance

Yuke He, Antonia E. Gallman, Chengmei Xie et al. · The Journal of Experimental Medicine · 2021 · 61 citations · Full text

Structure of the Human Protein Kinase ZAK in Complex with Vemurafenib

Sebastian Mathea, Kamal R. Abdul Azeez, E. Salah et al. · ACS Chemical Biology · 2016 · 25 citations · Full text

Drug Target, Kinase Inhibitors, Molecular Biology +22

Abcc1 and Ggt5 support lymphocyte guidance through export and catabolism of <i>S</i> -geranylgeranyl- <scp>l</scp> -glutathione

Antonia E. Gallman, Finn D. Wolfreys, David N. Nguyen et al. · Science Immunology · 2021 · 14 citations · Full text

Rows per page

1–5 of 5